Antibiotic Resistance Pattern of Bacteroides Fragilis Isolated from Clinical and Colorectal Specimens

Overview

Journal Ann Clin Microbiol Antimicrob

Publisher Biomed Central

Specialties Infectious Diseases
Microbiology

Date 2021 Apr 24

PMID 33892721

Citations 9

Authors

Seyedesomaye Jasemi

Mohammad Emaneini

Zahra Ahmadinejad

Mohammad Sadegh Fazeli

Leonardo A Sechi

Fatemah Sadeghpour Heravi

Mohammad Mehdi Feizabadi

Affiliations

Soon will be listed here.

Abstract

Background: Bacteroides fragilis is a part of the normal gastrointestinal flora, but it is also the most common anaerobic bacteria causing the infection. It is highly resistant to antibiotics and contains abundant antibiotic resistance mechanisms.

Methods: The antibiotic resistance pattern of 78 isolates of B. fragilis (22 strains from clinical samples and 56 strains from the colorectal tissue) was investigated using agar dilution method. The gene encoding Bacteroides fargilis toxin bft, and antibiotic resistance genes were targeted by PCR assay.

Results: The highest rate of resistance was observed for penicillin G (100%) followed by tetracycline (74.4%), clindamycin (41%) and cefoxitin (38.5%). Only a single isolate showed resistance to imipenem which contained cfiA and IS1186 genes. All isolates were susceptible to metronidazole. Accordingly, tetQ (87.2%), cepA (73.1%) and ermF (64.1%) were the most abundant antibiotic-resistant genes identified in this study. MIC values for penicillin, cefoxitin and clindamycin were significantly different among isolates with the cepA, cfxA and ermF in compare with those lacking such genes. In addition, 22.7 and 17.8% of clinical and GIT isolates had the bft gene, respectively.

Conclusions: The finding of this study shows that metronidazole is highly in vitro active agent against all of B. fragilis isolates and remain the first-line antimicrobial for empirical therapy.

Citing Articles

Ammonia and hydrogen sulfide - new insights into gut microbiota and male infertility through meta-analysis.

Hao Y, Du X, Cai C, Zhao Y, Ren Y Front Cell Infect Microbiol. 2025; 14():1449453.

PMID: 39835276 PMC: 11743720. DOI: 10.3389/fcimb.2024.1449453.

Editorial: The roles of pathogens in gut-related diseases and the strategies for inhibiting their growth.

Khan I, Gouxin H, Khan S, Ali A Front Pharmacol. 2024; 15:1513694.

PMID: 39697547 PMC: 11652199. DOI: 10.3389/fphar.2024.1513694.

Comparative analysis of the postadmission and antemortem oropharyngeal and rectal swab microbiota of ICU patients.

Petrilla A, Nemeth P, Fauszt P, Szilagyi-Racz A, Mikolas M, Szilagyi-Tolnai E Sci Rep. 2024; 14(1):27179.

PMID: 39516251 PMC: 11549221. DOI: 10.1038/s41598-024-78102-1.

Multi-omics approach for understanding the response of to carbapenems.

Zholdybayeva E, Kozhakhmetova S, Bayanbek D, Bekbayeva A, Auganova D, Kulmambetova G Heliyon. 2024; 10(17):e37049.

PMID: 39286136 PMC: 11402942. DOI: 10.1016/j.heliyon.2024.e37049.

New functions of pirin proteins and a 2-ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile.

Gough A, Parker A, OBryan P, Whitehead T, Roy S, Garcia B Microbiologyopen. 2024; 13(4):e1429.

PMID: 39109824 PMC: 11304471. DOI: 10.1002/mbo3.1429.

References

Snydman D, Jacobus N, McDermott L, Ruthazer R, Golan Y, Goldstein E . National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother. 2007; 51(5):1649-55. PMC: 1855532. DOI: 10.1128/AAC.01435-06. View

Rashidan M, Azimirad M, Alebouyeh M, Ghobakhlou M, Aghdaei H, Zali M . Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease. Anaerobe. 2018; 50:93-100. DOI: 10.1016/j.anaerobe.2018.02.005. View

Kierzkowska M, Majewska A, Szymanek-Majchrzak K, Sawicka-Grzelak A, Mlynarczyk A, Mlynarczyk G . The presence of antibiotic resistance genes and bft genes as well as antibiotic susceptibility testing of Bacteroides fragilis strains isolated from inpatients of the Infant Jesus Teaching Hospital, Warsaw during 2007-2012. Anaerobe. 2019; 56:109-115. DOI: 10.1016/j.anaerobe.2019.03.003. View

Yekani M, Baghi H, Naghili B, Zununi Vahed S, Soki J, Memar M . To resist and persist: Important factors in the pathogenesis of Bacteroides fragilis. Microb Pathog. 2020; 149:104506. DOI: 10.1016/j.micpath.2020.104506. View

Liu C, Huang Y, Liao C, Yen L, Lin H, Hsueh P . Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agents Chemother. 2008; 52(9):3161-8. PMC: 2533455. DOI: 10.1128/AAC.00355-08. View

Yunoki T, Matsumura Y, Yamamoto M, Tanaka M, Hamano K, Nakano S . Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: A prospective multicenter surveillance study in Japan. Anaerobe. 2017; 48:215-223. DOI: 10.1016/j.anaerobe.2017.09.003. View

Soki J, Wybo I, Hajdu E, Ulger Toprak N, Jeverica S, Stingu C . A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects. Anaerobe. 2020; 62:102182. DOI: 10.1016/j.anaerobe.2020.102182. View

Jeverica S, Soki J, Premru M, Nagy E, Papst L . High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS. Anaerobe. 2019; 58:30-34. DOI: 10.1016/j.anaerobe.2019.01.011. View

Akhi M, Ghotaslou R, Beheshtirouy S, Asgharzadeh M, Pirzadeh T, Asghari B . Antibiotic Susceptibility Pattern of Aerobic and Anaerobic Bacteria Isolated From Surgical Site Infection of Hospitalized Patients. Jundishapur J Microbiol. 2015; 8(7):e20309. PMC: 4584138. DOI: 10.5812/jjm.20309v2. View

10.

Jasemi S, Emaneini M, Fazeli M, Ahmadinejad Z, Nomanpour B, Sadeghpour Heravi F . Toxigenic and non-toxigenic patterns I, II and III and biofilm-forming ability in strains isolated from patients diagnosed with colorectal cancer. Gut Pathog. 2020; 12:28. PMC: 7273666. DOI: 10.1186/s13099-020-00366-5. View

11.

Kangaba A, Saglam F, Bahar Tokman H, Torun M, Mamal Torun M . The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey. Anaerobe. 2015; 35(Pt B):72-6. DOI: 10.1016/j.anaerobe.2015.07.008. View

12.

Rogers M, Parker A, Smith C . Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases. Antimicrob Agents Chemother. 1993; 37(11):2391-400. PMC: 192397. DOI: 10.1128/AAC.37.11.2391. View

13.

Soki J, Eitel Z, Urban E, Nagy E . Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int J Antimicrob Agents. 2012; 41(2):122-5. DOI: 10.1016/j.ijantimicag.2012.10.001. View

14.

Kierzkowska M, Majewska A, Szymanek-Majchrzak K, Sawicka-Grzelak A, Mlynarczyk A, Mlynarczyk G . In vitro effect of clindamycin against Bacteroides and Parabacteroides isolates in Poland. J Glob Antimicrob Resist. 2017; 13:49-52. DOI: 10.1016/j.jgar.2017.11.001. View

15.

Sarvari K, Soki J, Kristof K, Juhasz E, Miszti C, Latkoczy K . A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary. Infect Dis (Lond). 2018; 50(5):372-380. DOI: 10.1080/23744235.2017.1418530. View

16.

Boyanova L, Kolarov R, Mitov I . Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe. 2014; 31:4-10. DOI: 10.1016/j.anaerobe.2014.05.004. View

17.

Kouhsari E, Mohammadzadeh N, Kashanizadeh M, Saghafi M, Hallajzadeh M, Fattahi A . Antimicrobial resistance, prevalence of resistance genes, and molecular characterization in intestinal Bacteroides fragilis group isolates. APMIS. 2019; 127(6):454-461. DOI: 10.1111/apm.12943. View

18.

Salyers A, Gupta A, Wang Y . Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 2004; 12(9):412-6. DOI: 10.1016/j.tim.2004.07.004. View

19.

Fille M, Mango M, Lechner M, Schaumann R . Bacteroides fragilis group: trends in resistance. Curr Microbiol. 2006; 52(2):153-7. DOI: 10.1007/s00284-005-0249-x. View

20.

Cordovana M, Kostrzewa M, Soki J, Witt E, Ambretti S, Pranada A . Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories. Anaerobe. 2018; 54:246-253. DOI: 10.1016/j.anaerobe.2018.04.004. View